Scientists have created tiny disk-shaped particles that can swim on their own when hit with light, akin to microscopic robots ...

Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll ...

Revuforj is designed to treat patients with relapsed or refractory mutant NPM1 acute myeloid leukemia. The application has been assigned a real-time oncology review, which allows for a more efficient ...

Lupin launches Prucalopride tablets in US for chronic constipation treatment, bioequivalent to Motegrity, with estimated ...

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...

Mumbai: Global pharma major Lupin Limited has launched Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following ...

Secretary of State Marco Rubio announced that the Trump administration will implement new visa restrictions on certain ...

The initiative, referred to as the Commissioner’s National Priority Voucher program, allows drug developers to participate in a novel FDA priority program. The program significantly shortens the FDA ...

Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...

Pounding away on a prison typewriter, Chad Scott seemed worlds apart from President Donald Trump. But when the disgraced ...